Dr. Michael Barnett Discusses a Safe and Effective Treatment for ALS, MS

Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, recently announced results from 3 clinical trials that demonstrated the clinical benefit and safety of CNM-Au8, an oral suspension of gold nanocrystals developed to restore neuronal health and function, for the treatment of amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). To discuss the results and their implications, DocWire News spoke with Michael Barnett, MBBS, PhD, one of the trial’s key clinical advisors.